Conmed CNMD announced its Q4 earnings on Wednesday, February 5, 2025 at 04:05 PM.
Here’s a breakdown of the earnings report.
Earnings
Conmed beat estimated earnings by 12.0%, reporting an EPS of $1.34 versus an estimate of $1.2.
Revenue was up $18.90 million from the same period last year.
Past Earnings Performance
During the previous quarter, the company beat on EPS by $0.06, leading to a 5.0% increase share price change the next day.
Here’s a look at Conmed’s past performance:
Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
---|---|---|---|---|
EPS Estimate | 0.99 | 0.91 | 0.74 | 1.11 |
EPS Actual | 1.05 | 0.98 | 0.79 | 1.06 |
Revenue Estimate | 318.13M | 332.32M | 306.78M | 332.20M |
Revenue Actual | 316.70M | 332.10M | 312.27M | 327.05M |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
Conmed management provided guidance for FY 2025, expecting earnings between $4.25 and $4.4 per share.
To track all earnings releases for Conmed visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Overview Rating:
Speculative
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.